Literature DB >> 20969552

Gout and its comorbidities.

Michael H Pillinger1, David S Goldfarb, Robert T Keenan.   

Abstract

Gout is a chronic disease in which excessively high levels of serum urate (hyperuricemia) result in tissue depositions of sodium urate crystals and intermittent inflammatory attacks. Patients who have gout frequently experience a range of comorbidities, which complicates management and affects long-term prognosis. We review some of the more important of these comorbidities and consider the extent to which gout or hyperuricemia may be either a consequence or a cause of these related conditions. In addition, we briefly consider several neurological conditions in which the presence of gout or a high serum urate level may be associated with less disease, rather than more.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969552

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  22 in total

Review 1.  Metabolic regulation of inflammasomes in inflammation.

Authors:  Qiuli Yang; Ruichen Liu; Qing Yu; Yujing Bi; Guangwei Liu
Journal:  Immunology       Date:  2019-04-08       Impact factor: 7.397

Review 2.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

Review 3.  Uric acid as a danger signal in gout and its comorbidities.

Authors:  Kenneth L Rock; Hiroshi Kataoka; Jiann-Jyh Lai
Journal:  Nat Rev Rheumatol       Date:  2012-09-04       Impact factor: 20.543

4.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

Review 5.  Genetics of hyperuricemia and gout: implications for the present and future.

Authors:  Ronald L George; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

Review 6.  [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].

Authors:  L Sellin; J T Kielstein; K de Groot
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

7.  Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.

Authors:  Seoyoung C Kim; Bernhard M W Schmidt; Jessica M Franklin; Jun Liu; Daniel H Solomon; Sebastian Schneeweiss
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-12       Impact factor: 4.794

Review 8.  Chinese herbal medicine for gout: a systematic review of randomized clinical trials.

Authors:  Xin-Xue Li; Mei Han; Yu-Yi Wang; Jian-Ping Liu
Journal:  Clin Rheumatol       Date:  2013-05-11       Impact factor: 2.980

9.  Urate crystal deposition, prevention and various diagnosis techniques of GOUT arthritis disease: a comprehensive review.

Authors:  Panchatcharam Parthasarathy; S Vivekanandan
Journal:  Health Inf Sci Syst       Date:  2018-10-08

Review 10.  Asymptomatic hyperuricemia: is it time to intervene?

Authors:  Binoy J Paul; K Anoopkumar; Vinod Krishnan
Journal:  Clin Rheumatol       Date:  2017-10-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.